Medigen Biotechnology Market Cap

Medigen Biotechnology has a market cap or net worth of 4.23 billion as of August 15, 2025. Its market cap has decreased by -30.16% in one year.

Market Cap

4.23B

Enterprise Value

6.04B

Revenue

1.62B

Ranking

n/a

PE Ratio

n/a

Stock Price

30.40

Market Cap Chart

Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.23B, an increase of 518.63%. That is a compound annual growth rate of 9.16%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	4.23B	-6.17%
Dec 31, 2024	4.51B	-27.70%
Dec 29, 2023	6.24B	33.24%
Dec 30, 2022	4.69B	-41.43%
Dec 30, 2021	8.00B	-2.78%
Dec 31, 2020	8.23B	-4.46%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	208.61B
PharmaEssentia	167.97B
Bora Pharmaceuticals Co., LTD.	94.94B
Lotus Pharmaceutical	54.57B
Oneness Biotech	32.28B
Polaris Group	27.70B
Center Laboratories	26.60B
Lumosa Therapeutics	25.91B

Market Cap Rankings